Diagnocure, Inc.
Diagnocure, Inc. (DGCRF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DGCRF · as of Jun 9, 2026
Key Statistics
Explore Diagnocure, Inc. Data
dgcrf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dgcrf competitorsDGCRF
CBDHF
CTBO
HGENQ
MGFRF
NLBSStock Performance
Full HistoryAbout Diagnocure, Inc.
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnost…
what is diagnocure, inc. · dgcrf stock overview · diagnocure, inc. company profile · who is diagnocure, inc. ceo · dgcrf OTC · diagnocure, inc. headquarters · diagnocure, inc. business segments
About Stock Overview & Key Data
Diagnocure, Inc. (DGCRF) is a Healthcare company in the Medical - Specialties industry, listed on OTC since Sep 8, 2009. As of the latest trading session, DGCRF stock price is $0.00, with a market capitalization of $21,520. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2015, Diagnocure, Inc. reported revenue of $515372.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Diagnocure, Inc. (DGCRF) stock price is $0.00. The stock is traded on OTC under the ticker symbol DGCRF. The 52-week range is $0.00 – $0.00.